Ovarian cancer is the most lethal gynecologic cancer and a leading cause of cancer-related death in women. The survival rate has barely improved since the “War on Cancer” was declared over 40 years ago. Due to the lack of an early detection test, over 80% of patients are diagnosed at a late stage. For these reasons, increased awareness and advocacy are critical.
Working collaboratively to end ovarian cancer and improve the lives of survivors.
The Michigan Ovarian Cancer Alliance (MIOCA) strives to save lives by promoting the early detection of ovarian cancer and improved treatment outcomes. MIOCA raises awareness of ovarian cancer, provides resources and support to survivors and their families, advocates both locally and federally, educates Michigan communities, and funds innovative ovarian cancer research.
MIOCA is a 501(c)3 nonprofit. MIOCA serves survivors and their families by providing information, resources and support services as well as advocating for increased research and access to care. MIOCA serves the public by educating both women and healthcare professionals to better recognize ovarian cancer symptoms to help save lives through earlier detection. MIOCA is invested in Michigan's scientific community by awarding ovarian cancer research grants totaling $200,000 to date. What is raised in Michigan, stays in Michigan, as MIOCA works on behalf of the ovarian cancer community.
Established in 2011, MIOCA is a Community Partner of the Ovarian Cancer Research Alliance.